User profiles for Françoise Smets

Françoise Smets

UCLouvain, Cliniques universitaires Saint-Luc
Verified email at uclouvain.be
Cited by 6487

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and …

…, M Haumont, A Bollen, F Smets… - Journal of Infectious …, 2007 - academic.oup.com
Background. To date, there is no commercially available vaccine to prevent infectious
mononucleosis, a disease frequently induced by Epstein-Barr virus (EBV) infection in adolescents …

Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up1

EM Sokal, F Smets, A Bourgois… - …, 2003 - journals.lww.com
Hepatocyte transplantation is an investigational alternative to orthotopic liver transplantation
to treat liver based inborn errors of metabolism. We report successful hepatocyte …

Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement

…, L Hierro, G Indolfi, J Jahnel, F Smets… - Journal of pediatric …, 2018 - journals.lww.com
Paediatric autoimmune liver disease is characterized by inflammatory liver histology, circulating
autoantibodies, and increased levels of IgG, in the absence of a known etiology. Three …

Accuracy in diagnosis of celiac disease without biopsies in clinical practice

…, G Castillejo, K Kurppa, R Shamir, AC Hauer, F Smets… - Gastroenterology, 2017 - Elsevier
Background & Aims The guidelines of the European Society of Pediatric Gastroenterology,
Hepatology, and Nutrition allow for diagnosis of celiac disease without biopsies in children …

Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency

…, M Najimi, C Sibille, MC Nassogne, F Smets… - Gastroenterology, 2006 - Elsevier
Background & Aims: Donor cell engraftment with expression of enzyme activity is the goal of
liver cell transplantation for inborn errors of liver metabolism with a view to achieving …

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults

M Moutschen, P Léonard, EM Sokal, F Smets… - Vaccine, 2007 - Elsevier
Two double-blind randomised controlled studies (phase I and I/II) were performed to assess
for the first time the safety and immunogenicity of a recombinant subunit gp350 Epstein–Barr …

Anoikis: roadblock to cell transplantation?

I Zvibel, F Smets, H Soriano - Cell transplantation, 2002 - journals.sagepub.com
Cell therapy, in particular liver cell transplantation, holds great therapeutic potential and is
partially hindered by the high rate of apoptosis during cell isolation, cryopreservation, and …

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1

F Smets, D Latinne, H Bazin, R Reding, JB Otte… - …, 2002 - journals.lww.com
Background. Posttransplant lymphoproliferative disease (PTLD) is closely linked to primary
Epstein-Barr virus (EBV) infection and a defect of EBV specific cellular immunity is supposed …

Treatment of chronic hepatitis C virus infection in children: a position paper by the Hepatology Committee of European Society of Paediatric Gastroenterology …

…, W Van Der Woerd, F Smets… - Journal of pediatric …, 2018 - journals.lww.com
Objectives: In 2017, the European Medicines Agency and the Food and Drug Administration
approved the use of the fixed-dose combination of ledipasvir/sofosbuvir and of the …

[PDF][PDF] Human skin fibroblasts: From mesodermal to hepatocyte‐like differentiation

PA Lysy, F Smets, C Sibille, M Najimi, EM Sokal - Hepatology, 2007 - Wiley Online Library
The phenotypic homology of fibroblasts and mesenchymal stem cells (MSCs) has been
recently described. Our study investigated the in vitro potential of human skin fibroblasts to …